跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 328,637 条关于
“HAM-A”
全部
328,637
临床试验
277,870
药物
6,002
机构
4,033
资讯
40,732
前天
Definium Therapeutics to Report Phase 3 Panorama Topline Results for LSD-Based Anxiety Drug DT120
前天
Definium's DT120 ODT Hits Primary Endpoint in Second Phase 3 GAD Win, Setting Up First Psychedelic NDA for Anxiety
2年前
MindMed's MM120 Receives FDA Breakthrough Therapy Designation for Generalized Anxiety Disorder
去年
MindMed Advances MM120 for GAD with Phase 3 Trials Underway
上个月
APA 2026: Real-World GAD Treatment Gaps and Preclinical Safety Data for 5-HT2A Agonist DT120
去年
Lipocine Initiates Phase 3 Trial for Oral Brexanolone in Postpartum Depression
去年
MindMed's MM120 Shows Promise in GAD Treatment, Prepares for Phase III Trials
去年
MindBio's MB22001 Microdosing Formulation Shows Promise for Depression Treatment with Long-Term Stability
去年
MindBio Reaches Milestone in Phase 2B Microdosing Trial for Advanced Cancer Patients
5个月前
Viatris Secures First-Ever GAD Treatment Approval in Japan with Effexor
第 1 页,共 4074 页
上一页
下一页